Development of plant-derived, resistance-breaking mosquitocides for controlling vectors of Zika virus

开发植物源性杀蚊剂来控制寨卡病毒载体

基本信息

  • 批准号:
    9291272
  • 负责人:
  • 金额:
    $ 19.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-10 至 2018-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary The yellow fever mosquito Aedes aegypti is the principal vector of several medically-important arboviruses, such as Zika, chikungunya, and dengue. The control of mosquito-borne diseases relies on the use of insecticides targeting the nervous system of mosquitoes (e.g., pyrethroids) to reduce their populations. However, the emergence of insecticide resistance in mosquitoes has reduced the efficacy of these control agents. Thus, new insecticides targeting novel molecular and physiological targets are needed to embellish our chemical toolbox for vector control. We have recently discovered a drimane sesquiterpene dialdehyde (cinnamodial, CDIAL) from the bark of an endemic plant of Madagascar (Cinnamosma fragrans; family Canellaceae) that is toxic to adult female and larval Ae. aegypti. Moreover, CDIAL is equally toxic to representative pyrethroid-susceptible (Liverpool) and pyrethroid-resistant (Puerto Rico) strains of Ae. aegypti, suggesting a novel mechanism of action from pyrethroids. The goals of the proposed research are to 1) elucidate the structure-toxicity relationship of CDIAL against Ae. aegypti, and 2) develop natural and synthetic analogs of CDIAL with improved efficacy as mosquitocides. Aim 1 will use leading-edge natural product drug discovery, biotransformation, and medicinal chemistry approaches to develop a library of CDIAL analogs. Aim 2 will evaluate the toxicity of the analogs in larval and adult female Ae. aegypti from pyrethroid-susceptible and pyrethroid-resistant strains. Analogs with improved potency compared to CDIAL will be assessed for potential mammalian/human safety using an in vitro cytotoxicity assay with a normal cell line (African green monkey Vero cells). The results from the two aims will yield a diverse collection of natural compounds and their synthetic derivatives that offer high potential for development into safe, resistance-breaking mosquitocides for controlling the primary vector of Zika, dengue, and chikungunya viruses.
项目摘要 黄热病蚊子埃及伊蚊是几种医学上重要的虫媒病毒的主要载体, 如寨卡病毒、基孔肯雅病毒和登革热。蚊子传播疾病的控制依赖于使用 靶向蚊子神经系统的杀虫剂(例如,拟除虫菊酯),以减少其种群。 然而,蚊子抗药性的出现降低了这些控制的效果 剂.因此,需要靶向新的分子和生理靶标的新杀虫剂来修饰我们的环境。 用于病媒控制的化学工具箱。我们最近发现了一种补身烷倍半萜二醛 (肉桂醛,CDIAL)来自马达加斯加特有植物(肉桂属;科 Canellaceae),对成年雌性和幼虫Ae有毒。埃及人。此外,CDIAL对 代表性的拟除虫菊酯敏感(利物浦)和拟除虫菊酯抗性(波多黎各)菌株。埃及人, 表明拟除虫菊酯的一种新的作用机制。本研究的目的是:(1) 阐明了CDIAL对Ae.埃及,2)开发天然和合成 作为杀蚊剂具有改进功效的CDIAL类似物。目标1将使用领先的天然产物药物 发现、生物转化和药物化学方法来开发CDIAL类似物的文库。目的 2将评估类似物在幼虫和成年雌性Ae中的毒性。埃及伊蚊对拟除虫菊酯敏感, 拟除虫菊酯抗性菌株。将评估与CDIAL相比效价提高的类似物的潜在 使用正常细胞系(非洲绿色猴)进行的体外细胞毒性试验的哺乳动物/人类安全性 Vero细胞)。这两个目标的结果将产生各种各样的天然化合物及其用途。 合成衍生物,为开发安全、破坏抗性的灭蚊剂提供了很大的潜力, 控制寨卡病毒、登革热病毒和基孔肯雅病毒的主要载体。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter M Piermarini其他文献

Peter M Piermarini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter M Piermarini', 18)}}的其他基金

Gap Junction-mediated Regulation of the V-type H+-ATPase in a Renal Epithelium
间隙连接介导的肾上皮细胞中 V 型 H-ATP 酶的调节
  • 批准号:
    8290440
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
Gap Junction-mediated Regulation of the V-type H+-ATPase in a Renal Epithelium
间隙连接介导的肾上皮细胞中 V 型 H-ATP 酶的调节
  • 批准号:
    8191106
  • 财政年份:
    2011
  • 资助金额:
    $ 19.31万
  • 项目类别:
An epithelial model for V-type H+-ATPase-driven acid-base transport
V型H-ATP酶驱动的酸碱运输的上皮模型
  • 批准号:
    7920584
  • 财政年份:
    2009
  • 资助金额:
    $ 19.31万
  • 项目类别:
An epithelial model for V-type H+-ATPase-driven acid-base transport
V型H-ATP酶驱动的酸碱转运的上皮模型
  • 批准号:
    8280564
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
An epithelial model for V-type H+-ATPase-driven acid-base transport
V型H-ATP酶驱动的酸碱运输的上皮模型
  • 批准号:
    7579850
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
An epithelial model for V-type H+-ATPase-driven acid-base transport
V型H-ATP酶驱动的酸碱运输的上皮模型
  • 批准号:
    7363197
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
An epithelial model for V-type H+-ATPase-driven acid-base transport
V型H-ATP酶驱动的酸碱转运的上皮模型
  • 批准号:
    7781394
  • 财政年份:
    2008
  • 资助金额:
    $ 19.31万
  • 项目类别:
Structural Aspects of Bicarbonate Transport Metabolons
碳酸氢盐转运代谢的结构方面
  • 批准号:
    6889233
  • 财政年份:
    2004
  • 资助金额:
    $ 19.31万
  • 项目类别:
Structural Aspects of Bicarbonate Transport Metabolons
碳酸氢盐转运代谢的结构方面
  • 批准号:
    6792429
  • 财政年份:
    2004
  • 资助金额:
    $ 19.31万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 19.31万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了